DHT vs. HRMY
DHT (DHT Holdings, Inc.) and HRMY (Harmony Biosciences Holdings, Inc.) are both stocks. DHT operates in Oil & Gas Midstream (Energy), while HRMY operates in Biotechnology (Healthcare). Over the past 5 years, DHT returned 30.91%/yr vs 1.50%/yr for HRMY. At a 0.08 correlation, their price movements are largely independent.
Performance
DHT vs. HRMY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, DHT achieves a 52.86% return, which is significantly higher than HRMY's -7.91% return.
DHT
- 1D
- 5.53%
- 1M
- 1.99%
- YTD
- 52.86%
- 6M
- 50.04%
- 1Y
- 59.13%
- 3Y*
- 39.20%
- 5Y*
- 30.91%
- 10Y*
- 21.56%
HRMY
- 1D
- -2.10%
- 1M
- 12.03%
- YTD
- -7.91%
- 6M
- -14.93%
- 1Y
- 4.52%
- 3Y*
- -1.66%
- 5Y*
- 1.50%
- 10Y*
- —
DHT vs. HRMY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
DHT DHT Holdings, Inc. | 52.86% | 40.04% | 3.58% | 24.07% | 73.87% | 1.41% | -5.48% |
HRMY Harmony Biosciences Holdings, Inc. | -7.91% | 8.75% | 6.53% | -41.38% | 29.22% | 17.95% | -9.60% |
Correlation
The correlation between DHT and HRMY is -0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.06 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.02 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.07 |
Correlation (All Time) Calculated using the full available price history since Aug 19, 2020 | 0.08 |
The correlation between DHT and HRMY shifts across timeframes, from -0.06 (1 year) to 0.08 (all time), reflecting how their relationship changes across market environments.
Fundamentals
DHT:
$2.83B
HRMY:
$2.03B
DHT:
$2.06
HRMY:
$2.48
DHT:
8.53
HRMY:
13.88
DHT:
0.29
HRMY:
0.14
DHT:
4.99
HRMY:
2.25
DHT:
2.30
HRMY:
2.22
DHT:
$566.07M
HRMY:
$899.11M
DHT:
$268.69M
HRMY:
$688.25M
DHT:
$450.13M
HRMY:
$221.74M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DHT vs. HRMY — Risk / Return Rank
DHT
HRMY
DHT vs. HRMY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for DHT Holdings, Inc. (DHT) and Harmony Biosciences Holdings, Inc. (HRMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| DHT | HRMY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.86 | ||
| Sortino ratioReturn per unit of downside risk | +2.29 | ||
| Omega ratioGain probability vs. loss probability | 1.31 | 1.06 | +0.25 |
| Calmar ratioReturn relative to maximum drawdown | 4.36 | 0.10 | +4.26 |
| Martin ratioReturn relative to average drawdown | 8.98 | 0.18 | +8.79 |
Loading charts...
Drawdowns
DHT vs. HRMY - Drawdown Comparison
The maximum DHT drawdown since its inception was -97.12%, which is greater than HRMY's maximum drawdown of -68.48%. Use the drawdown chart below to compare losses from any high point for DHT and HRMY.
Loading charts...
Drawdown Indicators
| DHT | HRMY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.12% | -68.48% | -28.64% |
Max Drawdown (1Y)Largest decline over 1 year | -15.22% | -34.49% | +19.27% |
Max Drawdown (3Y)Largest decline over 3 years | -24.96% | -50.81% | +25.85% |
Max Drawdown (5Y)Largest decline over 5 years | -34.44% | -68.48% | +34.04% |
Max Drawdown (10Y)Largest decline over 10 years | -39.56% | — | — |
Current DrawdownCurrent decline from peak | -64.71% | -43.42% | -21.29% |
Average DrawdownAverage peak-to-trough decline | -76.36% | -35.27% | -41.09% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.37% | 18.73% | -11.36% |
Volatility
DHT vs. HRMY - Volatility Comparison
The current volatility for DHT Holdings, Inc. (DHT) is 9.92%, while Harmony Biosciences Holdings, Inc. (HRMY) has a volatility of 11.05%. This indicates that DHT experiences smaller price fluctuations and is considered to be less risky than HRMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| DHT | HRMY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.92% | 11.05% | -1.13% |
Volatility (6M)Calculated over the trailing 6-month period | 27.38% | 30.44% | -3.06% |
Volatility (1Y)Calculated over the trailing 1-year period | 34.13% | 42.03% | -7.90% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 38.32% | 50.13% | -11.81% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 41.60% | 52.45% | -10.85% |
Dividends
DHT vs. HRMY - Dividend Comparison
DHT's dividend yield for the trailing twelve months is around 8.37%, while HRMY has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
DHT DHT Holdings, Inc. | 8.37% | 6.06% | 10.76% | 11.72% | 1.35% | 2.50% | 25.81% | 2.42% | 2.04% | 5.57% | 17.15% | 6.55% |
HRMY Harmony Biosciences Holdings, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
DHT vs. HRMY - Financials Comparison
This section allows you to compare key financial metrics between DHT Holdings, Inc. and Harmony Biosciences Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
DHT vs. HRMY - Profitability Comparison
DHT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, DHT Holdings, Inc. reported a gross profit of 112.62M and revenue of 186.48M. Therefore, the gross margin over that period was 60.4%.
HRMY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Harmony Biosciences Holdings, Inc. reported a gross profit of 170.88M and revenue of 215.39M. Therefore, the gross margin over that period was 79.3%.
DHT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, DHT Holdings, Inc. reported an operating income of 107.66M and revenue of 186.48M, resulting in an operating margin of 57.7%.
HRMY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Harmony Biosciences Holdings, Inc. reported an operating income of 37.29M and revenue of 215.39M, resulting in an operating margin of 17.3%.
DHT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, DHT Holdings, Inc. reported a net income of 164.53M and revenue of 186.48M, resulting in a net margin of 88.2%.
HRMY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Harmony Biosciences Holdings, Inc. reported a net income of 32.49M and revenue of 215.39M, resulting in a net margin of 15.1%.
Frequently Asked Questions
DHT and HRMY have a correlation of -0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
HRMY has higher volatility (11.05%) compared to DHT (9.92%). In terms of maximum drawdown, DHT dropped -97.12% vs HRMY's -68.48%.
DHT currently has the higher Sharpe Ratio (1.95 vs 0.08), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for DHT and HRMY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer